202 related articles for article (PubMed ID: 30371293)
1. Comparison of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Management Strategies Before Cardiac Surgery: A Pilot Randomized Controlled Registry Trial.
van Diepen S; Norris CM; Zheng Y; Nagendran J; Graham MM; Gaete Ortega D; Townsend DR; Ezekowitz JA; Bagshaw SM
J Am Heart Assoc; 2018 Oct; 7(20):e009917. PubMed ID: 30371293
[TBL] [Abstract][Full Text] [Related]
2. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
[TBL] [Abstract][Full Text] [Related]
4. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.
Lopes RD; Macedo AVS; de Barros E Silva PGM; Moll-Bernardes RJ; Dos Santos TM; Mazza L; Feldman A; D'Andréa Saba Arruda G; de Albuquerque DC; Camiletti AS; de Sousa AS; de Paula TC; Giusti KGD; Domiciano RAM; Noya-Rabelo MM; Hamilton AM; Loures VA; Dionísio RM; Furquim TAB; De Luca FA; Dos Santos Sousa ÍB; Bandeira BS; Zukowski CN; de Oliveira RGG; Ribeiro NB; de Moraes JL; Petriz JLF; Pimentel AM; Miranda JS; de Jesus Abufaiad BE; Gibson CM; Granger CB; Alexander JH; de Souza OF;
JAMA; 2021 Jan; 325(3):254-264. PubMed ID: 33464336
[TBL] [Abstract][Full Text] [Related]
5. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.
White CM; Kluger J; Lertsburapa K; Faheem O; Coleman CI
Eur J Cardiothorac Surg; 2007 May; 31(5):817-20. PubMed ID: 17350856
[TBL] [Abstract][Full Text] [Related]
6. Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.
Cohen JB; Hanff TC; William P; Sweitzer N; Rosado-Santander NR; Medina C; Rodriguez-Mori JE; Renna N; Chang TI; Corrales-Medina V; Andrade-Villanueva JF; Barbagelata A; Cristodulo-Cortez R; Díaz-Cucho OA; Spaak J; Alfonso CE; Valdivia-Vega R; Villavicencio-Carranza M; Ayala-García RJ; Castro-Callirgos CA; González-Hernández LA; Bernales-Salas EF; Coacalla-Guerra JC; Salinas-Herrera CD; Nicolosi L; Basconcel M; Byrd JB; Sharkoski T; Bendezú-Huasasquiche LE; Chittams J; Edmonston DL; Vasquez CR; Chirinos JA
Lancet Respir Med; 2021 Mar; 9(3):275-284. PubMed ID: 33422263
[TBL] [Abstract][Full Text] [Related]
7. Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.
Bhandari S; Ives N; Brettell EA; Valente M; Cockwell P; Topham PS; Cleland JG; Khwaja A; El Nahas M
Nephrol Dial Transplant; 2016 Feb; 31(2):255-61. PubMed ID: 26429974
[TBL] [Abstract][Full Text] [Related]
8. Preoperative treatment with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker has no beneficial effect on the development of new-onset atrial fibrillation after off-pump coronary artery bypass graft surgery.
Chin JH; Lee EH; Son HJ; Kim WJ; Choi DK; Park SK; Sim JY; Choi IC; Hahm KD
Clin Cardiol; 2012 Jan; 35(1):37-42. PubMed ID: 22020954
[TBL] [Abstract][Full Text] [Related]
9. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery.
Coca SG; Garg AX; Swaminathan M; Garwood S; Hong K; Thiessen-Philbrook H; Passik C; Koyner JL; Parikh CR;
Nephrol Dial Transplant; 2013 Nov; 28(11):2787-99. PubMed ID: 24081864
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
11. The effect of continuing versus withholding angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers on mortality and major adverse cardiovascular events in hypertensive patients undergoing elective non-cardiac surgery: study protocol for a multi-centric open-label randomised controlled trial.
Misra S; Parida S; Sahajanandan R; Behera BK; Senthilnathan M; Mariappan R; Chandy TT;
Trials; 2022 Aug; 23(1):670. PubMed ID: 35978368
[TBL] [Abstract][Full Text] [Related]
12. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention.
Byun JK; Choi BG; Rha SW; Choi SY; Jeong MH;
Atherosclerosis; 2018 Oct; 277():130-135. PubMed ID: 30212681
[TBL] [Abstract][Full Text] [Related]
13. New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT.
King JB; Berchie RO; Derington CG; Marcum ZA; Scharfstein DO; Greene TH; Herrick JS; Jacobs JA; Zheutlin AR; Bress AP; Cohen JB
J Am Heart Assoc; 2023 Sep; 12(17):e030311. PubMed ID: 37646208
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI;
Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome.
Manning MW; Cooter M; Mathew J; Alexander J; Peterson E; Ferguson TB; Lopes R; Podgoreanu M
Ann Thorac Surg; 2017 Jul; 104(1):98-105. PubMed ID: 28131423
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.
Bauer A; Schreinlechner M; Sappler N; Dolejsi T; Tilg H; Aulinger BA; Weiss G; Bellmann-Weiler R; Adolf C; Wolf D; Pirklbauer M; Graziadei I; Gänzer H; von Bary C; May AE; Wöll E; von Scheidt W; Rassaf T; Duerschmied D; Brenner C; Kääb S; Metzler B; Joannidis M; Kain HU; Kaiser N; Schwinger R; Witzenbichler B; Alber H; Straube F; Hartmann N; Achenbach S; von Bergwelt-Baildon M; von Stülpnagel L; Schoenherr S; Forer L; Embacher-Aichhorn S; Mansmann U; Rizas KD; Massberg S;
Lancet Respir Med; 2021 Aug; 9(8):863-872. PubMed ID: 34126053
[TBL] [Abstract][Full Text] [Related]
17. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
[TBL] [Abstract][Full Text] [Related]
18. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.
Hollmann C; Fernandes NL; Biccard BM
Anesth Analg; 2018 Sep; 127(3):678-687. PubMed ID: 29381513
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry.
Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
Int J Cardiol; 2018 Apr; 257():168-176. PubMed ID: 29506690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
